You are here

Pharmaceutical Approval Update January 2008

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include nilotinib (Tasigna Capsules) for the treatment of chronic mye­logenous leukemia (CML), raltegravir (Isentress) for patients with HIV-1 infection, and ixabepilone (Ixempra), combined with capecitabine (Xeloda), for use in metastatic or locally advanced breast cancer.